Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
In the absence of a current therapy to prevent facial lipoatrophy in HIV+ patients treated with HAART, surgical correction of the defect still remains the best option. We evaluate two different surgical techniques for facial contour enhancing and suggest the right choice related to the lipodystrophy severity. Twelve HIV+ patients underwent surgical submalar correction: eight were treated with lipofilling following Coleman's technique and four had bilateral malar silicone implants inserted after determining their positioning with the aid of a new software. Both techniques gave long lasting results in facial contour reshaping ranging from good to very good. No complication was observed. In the mean follow-up period of 2 years no patient felt uncomfortable with his/her image. Both techniques, lipofilling and silicone implant positioning, for managing facial lipoatrophy in HIV+ patients treated with HAART had good results, but the right choice has to be related to the severity of the lipodystrophy in the patient.
Mori
A
A
Department of Plastic Surgery, University of Florence, Largo Palagi 1, 50134 Florence, Italy. amdoc@tin.it
Lo Russo
G
G
Agostini
T
T
Pattarino
J
J
Vichi
F
F
Dini
M
M
D000273:Adipose Tissue / Q000637:transplantation*; D000328:Adult; D002610:Cheek / Q000601:surgery; D005145:Face / Q000473:pathology / Q000601:surgery*; D005260:Female; D039682:HIV-Associated Lipodystrophy Syndrome / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D019651:Plastic Surgery Procedures / Q000379:methods; D020034:Silicone Gels; D016896:Treatment Outcome
D020034:Silicone Gels